Efficacy and Safety of Bioactive Glass S53P4 as a Treatment for Diabetic Foot Osteomyelitis
نویسندگان
چکیده
منابع مشابه
Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis.
Bioactive glass (BAG)-S53P4 is an osteoconductive bone substitute with proven antibacterial and bone bonding properties. In a multicentre study 11 patients with verified chronic osteomyelitis in the lower extremity and the spine were treated with BAG-S53P4 as a bone substitute. The cavitary bone defect and the surrounding of a spinal implant were filled with BAG-S53P4. The most common pathogen ...
متن کاملPreparation and characterization of fluorapatite-bioactive glass S53P4 nanocomposite
This research has been done to study characteristic and biocompatible evaluation of a nano-biocompositeceramic with the bioglass (BG) as a first phase. In this regard, synthesis of S53P4 (53% SiO2, 4% P2O5,23% Na2O and 20% CaO) bioglass has been considered as the first phase and flourapatite (FA) consideredas the second phase. Afterwards, nanocomposite with the base of S53P4 b...
متن کاملClinical Applications of S53P4 Bioactive Glass in Bone Healing and Osteomyelitic Treatment: A Literature Review
Nowadays, S53P4 bioactive glass is indicated as a bone graft substitute in various clinical applications. This review provides an overview of the current published clinical results on indications such as craniofacial procedures, grafting of benign bone tumour defects, instrumental spondylodesis, and the treatment of osteomyelitis. Given the reported results that are based on examinations, such ...
متن کاملTreatment of Cavitary Bone Defects in Chronic Osteomyelitis: Biogactive glass S53P4 vs. Calcium Sulphate Antibiotic Beads
Aim: To evaluate the efficacy of bioglass (BAG-S53P4) in the treatment of patients with chronic osteomyelitis and compare the results with calcium sulphate antibiotic beads in one medical centre. Methods: Retrospective analysis of 25 cases. INCLUSION CRITERIA patients diagnosed clinically and radiographically of osteomyelitis and treated surgically (Group 1: cavitary bone defects treated with...
متن کاملOsteomyelitis and the Diabetic Foot
Diabetic foot infections are associated with significant morbidity, account for the largest number of diabetesrelated hospital bed days and contribute to 50% of all lower extremity amputations in the United States. The annual incidence of foot ulcers in diabetic patients is about 2%, which, given that there are now 15-20 million diabetics nationally, extrapolates to over 300,000 cases per year....
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Foot and Ankle Surgery
سال: 2021
ISSN: 1067-2516
DOI: 10.1053/j.jfas.2020.06.029